Effect of different molecular weight hyaluronans on osteoarthritis-related protein production in fibroblast-like synoviocytes from patients with tibia plateau fracture

Journal of Trauma - Injury, Infection and Critical Care

Volumn 68, Issue 1, 2010, Pages 146-152

  Huang, Teng Le ^a,b   Hsu, Horng Chaung ^b   Yang, Kai Chiang ^a   Yao, Chun Hsu ^b   Lin, Feng Huei ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Fracture; Hyaluronan; Synoviocytes

Indexed keywords

HYALURONIC ACID; INTERLEUKIN 10; INTERLEUKIN 1BETA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; VISCOSUPPLEMENT;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHONDROPROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FIBROBLAST; HUMAN; HUMAN CELL; KNEE MENISCUS RUPTURE; MOLECULAR WEIGHT; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIOCYTE; TIBIA FRACTURE; UPREGULATION; ADOLESCENT; ARTHROSCOPY; CELL CULTURE; CYTOLOGY; INJURY; INTRAARTICULAR DRUG ADMINISTRATION; INTRAARTICULAR FRACTURE; KNEE MENISCUS; KNEE OSTEOARTHRITIS; METABOLISM; MIDDLE AGED; PATHOLOGY; SYNOVIUM;

ADOLESCENT; ADULT; ARTHROSCOPY; CELLS, CULTURED; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; INTERLEUKIN-1BETA; INTRA-ARTICULAR FRACTURES; MATRIX METALLOPROTEINASE 3; MENISCI, TIBIAL; MIDDLE AGED; MOLECULAR WEIGHT; OSTEOARTHRITIS, KNEE; SYNOVIAL MEMBRANE; TIBIAL FRACTURES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR NECROSIS FACTOR-ALPHA; VISCOSUPPLEMENTS; YOUNG ADULT;

EID: 75649147388     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181a92cf8     Document Type: Article

References (23)

1. Nolla J, Ring D, Lozano-Calderon S, Jupiter JB. Interposition arthroplasty of the elbow with hinged external fixation for post-traumatic arthritis. J Shoulder Elbow Surg. 2008;17:459-464
2. Malemud CJ, Islam N, Haqqi TM. Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs. 2003;174:34-48
3. Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J. Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol Suppl. 1995; 43:109-114
4. Laurent TC, Laurent UB, Fraser JR. The structure of hyaluronan: an overview. Immunol Cell Biol. 1996;74:A1-A7
5. Pagnano M, Westrich G. Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans. Osteoarthritis Cartilage. 2005;13:751-761
6. Novaes AC, Schaiquevich P, Nasswetter G; The Latin American Group of Quality of Life in Rheumatology. Multicenter study of hyaluronic acid obtained by biotechnology to evaluate clinical efficacy and safety in knee osteoarthritis. Int J Clin Pharmacol Res. 2005;25:1-7
7. Lee PB, Kim YC, Lim YJ, et al. Comparison between high and low molecular weight hyaluronates in knee osteoarthritis patients: openlabel, randomized, multicentre clinical trial. J Int Med Res. 2006;34: 77-87
8. Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum. 2002;32:10-37
9. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis. 1957;16:494-502
10. Praest BM, Greiling H, Kock R. Assay of synovial fluid parameters: hyaluronan concentration as a potential marker for joint diseases. Clin Chim Acta. 1997;266:117-128
11. Dahl LB, Dahl IM, Engstrom-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985;44:817-822
12. Itano N, Sawai T, Yoshida M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem. 1999;272:25085-25092
13. Spicer AP, McDonald JA. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem. 1998;273: 1923-1932
14. Oguchi T, Ishiguro N. Differential stimulation of three forms of hyaluronan synthase by TGF-beta, IL-1beta, and TNF-alpha. Connect Tissue Res. 2004;45:197-205
15. Amiel D, Toyoguchi T, Kobayashi K, Bowden K, Amiel ME, Healey RM. Long-term effect of sodium hyaluronate (Hyalgan) on osteoarthritis progression in a rabbit model. Osteoarthritis Cartilage. 2003;11:636-643
16. Wenz W, Breusch SJ, Graf J, Stratmann U. Ultrastructural findings after intraarticular application of hyaluronan in a canine model of arthropathy. J Orthop Res. 2000;18:604-612 (Pubitemid 30786594)
17. Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritisassociated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage. 2006;14: 1237-1247
18. Sugimoto H, Yamada H, Terada N, et al. Intraarticular injection of high molecular weight hyaluronan for osteoarthritis of the knee-prediction of effectiveness with biological markers. J Rheumatol. 2006;33:2527
19. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis. 2005;64:1263-1267
20. Yasuda T. Hyaluronan inhibits cytokine production by lipopolysaccharidestimulated U937 macrophages through down-regulation of NF-kappaB via ICAM-1. Inflamm Res. 2007;56:246-253
21. Hiramitsu T, Yasuda T, Ito H, et al. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1betainduced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38. Rheumatology (Oxford). 2006;45:824-832
22. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS Jr. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem. 1999;274:31868-31874
23. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61:1303-1313